Joe Biden, the president, once more tests positive for COVID-19
The White House reported that S. President Joe Biden come back positive for COVID-19 once more, several days after being given the all-clear to leave coronavirus isolation, in a rare instance of "rebound" following anti-viral drug treatment.
In a message on Saturday, White House doctor Dr Kevin O'Connor stated that Biden "has experienced no reawakening of symptomatology, as well as begins to feel quite well."
Biden will resume isolation procedures. His positive test is thought to be a "rebound" joy and happiness witnessed by some COVID patients, thus according to O'Connor. Biden screened positive for the disorder nine days ago but afterwards tested negative twice previously this week.
In a Twitter post about his successful case, Biden stated that it can actually occur to a "small minority of people."
"I don't have any symptoms, but I'm going to isolate myself to protect those around me. I'm still at work, but I'm getting close to getting back on the road," he tweeted.
Folks, today I tested positive for COVID again.
— President Biden (@POTUS) July 30, 2022
This happens with a small minority of folks.
I’ve got no symptoms but I am going to isolate for the safety of everyone around me.
I’m still at work, and will be back on the road soon.
Biden will return to isolation for a minimum of five days in accordance with recommendations from the Centers for Disease and Prevention.
According to the agency, the majority of rebound cases are still mild, and no cases of severe illness during that time have been reported.
On July 21, Biden, 79, had his initial positive test; he was then given Paxlovid, an antiviral medication. The virus was not found in his blood samples on July 26 or 27. Then he was permitted to emerge from isolation while donning an indoor mask.
His positive tests place him in the small percentage of people who take the medication and develop a fastbreak case of the virus.
On Monday, Dr. Ashish Jha, the White House COVID-19 coordinator, told reporters that data "suggests that between 5 and 8% of people have rebound" after Paxlovid treatment.